Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer Meeting Abstract


Authors: Hong, D. S.; Drilon, A. E.; Tan, D. S. W.; Lin, Jessica J.; Kummar, S.; McDermott, R. S.; Berlin, J.; Italiano, A.; Lassen, U. N.; Leyvraz, S.; Tahara, M.; Norenberg, R.; Burcoveanu, D.; Brega, N.; Shen, L.
Abstract Title: Larotrectinib long-term efficacy and safety in adult patients (pts) with tropomyosin receptor kinase (TRK) fusion cancer
Meeting Title: 2023 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 41
Issue: 16 Suppl.
Meeting Dates: 2023 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2023-06-01
Language: English
DOI: 10.1200/JCO.2023.41.16_suppl.3141
PROVIDER: EBSCOhost
PROVIDER: cinahl
DOI/URL:
Notes: Meeting Abstract: 3141 -- This meeting was also held virtually -- Source: Cinahl
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Alexander Edward Drilon
    632 Drilon